BCL-2, a key regulator of apoptosis, is highly expressed in many SCLC tumors, and several studies suggest synergy between the inhibition of PI3K–mTOR and BCL-2 in SCLC [111]. The gene discussed is MTOR; the disease is small cell lung carcinoma.